Related Experiment Videos
[Plasma factors regulating prostacyclin synthesis during pregnancy]
Wiener Klinische Wochenschrift
|October 29, 1982
Summary
Plasma factor activity, which influences prostacyclin (PGI2) formation, increases during early pregnancy but significantly decreases by the end. Post-delivery levels normalize, though diabetes mellitus patients show reduced activity.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Reproductive Biology
Context:
- Prostacyclin (PGI2) is a key regulator of blood flow in maternal and fetal circulation.
- A "prostacyclin synthesis stimulating plasma factor" in human blood influences PGI2 production.
- Altered plasma factor activity is linked to disturbances in PGI2 metabolism.
Purpose:
- To investigate the activity of the prostacyclin synthesis stimulating plasma factor during pregnancy and postpartum.
- To compare plasma factor activity in pregnant individuals and those with diabetes mellitus to controls.
Summary:
- Plasma factor activity was elevated during the first and second trimesters of pregnancy.
- A significant decrease in plasma factor activity was observed at the end of pregnancy.
- One year postpartum, plasma factor activity returned to levels comparable to the control group.
- Patients with diabetes mellitus exhibited decreased plasma factor activity, yet followed a similar pattern to normal pregnancy.
Impact:
- This study elucidates the dynamic changes in prostacyclin regulation during pregnancy.
- Findings suggest potential implications for understanding pregnancy-related vascular complications and diabetes management.
- Identifies a novel biomarker for monitoring PGI2 metabolism in pregnant individuals.